Durable remission induced by rituximab-containing chemotherapy in a patient with primary refractory Burkitt's lymphoma

Annals of Hematology

Volumn 83, Issue 2, 2004, Pages 120-123

  Yokohama, A ^a   Tsukamoto, N ^a   Uchiumi, H ^a   Handa, H ^a   Matsushima, T ^a   Karasawa, M ^a   Murakami, H ^a   Nojima, Y ^a  

^a GUNMA UNIVERSITY   (Japan)

Author keywords

Burkitt's lymphoma; c myc; CD20; Rituximab; t(8; 14)

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; FLUORODEOXYGLUCOSE F 18; IMMUNOGLOBULIN G; METHOTREXATE; PREDNISONE; RITUXIMAB; VINCRISTINE;

ABDOMINAL DISEASE; ADVANCED CANCER; AGED; ARTICLE; B LYMPHOCYTE; BONE MARROW SUPPRESSION; BRONCHITIS; BURKITT LYMPHOMA; CANCER COMBINATION CHEMOTHERAPY; CANCER IMMUNOTHERAPY; CANCER REGRESSION; CASE REPORT; CELL MATURATION; EPIDIDYMITIS; FEVER; GENE REARRANGEMENT; HERPES ZOSTER; HUMAN; HUMAN CELL; HYPOGAMMAGLOBULINEMIA; ILEUS; IMMUNOPHENOTYPING; INTESTINE LYMPHOMA; MALE; MINIMAL RESIDUAL DISEASE; ONCOGENE C MYC; PANCYTOPENIA; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RECURRENT INFECTION; TREATMENT OUTCOME;

AGED; ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; B-LYMPHOCYTES; BURKITT LYMPHOMA; FLUORODEOXYGLUCOSE F18; GENES, MYC; HUMANS; L-LACTATE DEHYDROGENASE; MALE; RADIOPHARMACEUTICALS; REMISSION INDUCTION; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0742306795     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00277-003-0758-2     Document Type: Article

References (17)

1. Hecht J, Aster J (2000) Molecular biology of Burkitt's lymphoma. J Clin Oncol 18:3707 3721
2. Magrath I, Adde M, Shad A, et al. (1996) Adults and children with small non-cleaved-cell lymphoma have a similar excellent outcome when treated with the same chemotherapy regimen. J Clin Oncol 14:925 934
3. Patte C, Philip T, Rodary C, et al. (1991) High survival rate in advanced-stage B-cell lymphomas and leukemias without CNS involvement with a short intensive polychemotherapy: results from the French Pediatric Oncology Society of a randomized trial of 216 children. J Clin Oncol 9:123 132
4. Patte C, Auperin A, Michon J, et al. (2001) The Societe Francaise d'Oncologie Pediatrique LMB89 protocol: highly effective multiagent chemotherapy tailored to the tumor burden and initial response in 561 unselected children with B-cell lymphomas and L3 leukemia. Blood 97:3370 3379
5. Soussain C, Patte C, Ostronoff M, et al. (1995) Small noncleaved cell lymphoma and leukemia in adults. A retrospective study of 65 adults treated with the LMB pediatric protocols. Blood 85:664 674
6. Mead G, Sydes M, Walewski J, et al. (2002) An international evaluation of CODOX-M and CODOX-M alternating with IVAC in adult Burkitt's lymphoma: results of United Kingdom Lymphoma Group LY06 study. Ann Oncol 13:1264 1274
7. Lee E, Petroni G, Schiffer C, et al. (2001) Brief-duration high-intensity chemotherapy for patients with small noncleaved-cell lymphoma or FAB L3 acute lymphocytic leukemia: results of cancer and leukemia group B study 9251. J Clin Oncol 19:4014-4022
8. Maloney D, Grillo-Lopez A, White C, et al. (1997) IDEC-C2B8 (Rituximab) anti-CD20 monoclonal antibody therapy in patients with relapsed low-grade non-Hodgkin's lymphoma. Blood 90:2188-2195
9. Hainsworth J, Burris III H, Morrissey L, et al. (2000) Rituximab monoclonal antibody as initial systemic therapy for patients with low-grade non-Hodgkin lymphoma. Blood 95:3052-3056
10. Czuczman MS, Grillo-Lopez AJ, White CA, et al. (1999) Treatment of patients with low-grade B-cell Lymphoma with the combination of chimeric anti-CD20 monoclonal antibody and CHOP chemotherapy. J Clin Oncol 17:268-276
11. Coiffier B, Lepage E, Briere J, et al. (2002) CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. N Engl J Med 346:235-242
12. Thomas D, Cortes J, Giles F, et al. (2001) Rituximab and hyper-CVAD for adult Burkitt's (BL) or Burkitt's-like (BLL) leukemia or lymphoma. Blood 98:804a
13. Cohen Y, Amir G, Rachmilewitz E, et al. (2002) Sustained complete remission following a combination of very low intensity chemotherapy with rituximab in an elderly patient with Burkitt's lymphoma. Hematologica 87:ETL04
14. McGuirk JP, Dix SP, Belt RJ (2000) Rituximab and immune modulation post unrelated donor transplantation as treatment for refractory Burkitt's-like lymphoma (abstract 4775). Blood 96:242b
15. Akasaka T, Muramatsu M, Ohno H, et al. (1996) Application of long-distance polymerase chain reaction to detection of junctional sequence created by chromosomal translocation in mature B-cell neoplasms. Blood 88:985-994
16. Reiter A, Schrappe M, Tiemann M, et al. (1999) Improved treatment results in childhood B-cell neoplasms with tailored intensification of therapy: a report of the Berlin-Frankfurt-Munster Group trial NHL-BFM90. Blood 94:3294-3306
17. Vose J, Link B, Grossbard M, et al. (2001) Phase II study of rituximab in combination with CHOP chemotherapy in patients with previously untreated, aggressive non-Hodgkin's lymphoma. J Clin Oncol 19:389-397